FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Russell Petter

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Disorders

Procedures

Anatomy

Cerebral Cortex

Co-author Network

Publications

TOP 3
Chi B Vu; William F Kiesman; Patrick R Conlon; Ko-Chung Lin; Melissa Tam; Russell C Petter; Glenn Smits; Frank Lutterodt; Xiaowei Jin; Liqing Chen; Jianbo Zhang
Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists.
William F Kiesman; Jin Zhao; Patrick R Conlon; James E Dowling; Russell C Petter; Frank Lutterodt; Xiaowei Jin; Glenn Smits; Mary Fure; Andrew Jayaraj; John Kim; Gail Sullivan; Joel Linden
Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.
William F Kiesman; Jin Zhao; Patrick R Conlon; Russell C Petter; Xiaowei Jin; Glenn Smits; Frank Lutterodt; Gail W Sullivan; Joel Linden
Norbornyllactone-substituted xanthines as adenosine A(1) receptor antagonists.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Russell Petter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Chi B Vu; William F Kiesman; Patrick R Conlon; Ko-Chung Lin; Melissa Tam; Russell C Petter; Glenn Smits; Frank Lutterodt; Xiaowei Jin; Liqing Chen; Jianbo Zhang
Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists.
Journal of medicinal chemistry 2006;49(24):7132-9.
2006: William F Kiesman; Jin Zhao; Patrick R Conlon; James E Dowling; Russell C Petter; Frank Lutterodt; Xiaowei Jin; Glenn Smits; Mary Fure; Andrew Jayaraj; John Kim; Gail Sullivan; Joel Linden
Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.
Journal of medicinal chemistry 2006;49(24):7119-31.
2006: William F Kiesman; Jin Zhao; Patrick R Conlon; Russell C Petter; Xiaowei Jin; Glenn Smits; Frank Lutterodt; Gail W Sullivan; Joel Linden
Norbornyllactone-substituted xanthines as adenosine A(1) receptor antagonists.
Bioorganic & medicinal chemistry 2006;14(11):3654-61.
2006: Darren P Baker; Edward Y Lin; Kochung Lin; Maria Pellegrini; Russell C Petter; Ling Ling Chen; Robert M Arduini; Margot Brickelmaier; Dingyi Wen; Donna M Hess; Liqing Chen; Donna Grant; Adrian Whitty; Alan Gill; Daniel J Lindner; R Blake Pepinsky
N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
Bioconjugate chemistry 2006;17(1):179-88.
2005: James E Dowling; Jeffrey T Vessels; Serajul Haque; He Xi Chang; Kurt van Vloten; Gnanasambandam Kumaravel; Thomas Engber; Xiaowei Jin; Deepali Phadke; Joy Wang; Eman Ayyub; Russell C Petter
Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists.
Bioorganic & medicinal chemistry letters 2005;15(21):4809-13.
2005: Chi B Vu; Deborah Pan; Bo Peng; Gnanasambandam Kumaravel; Glenn Smits; Xiaowei Jin; Deepali Phadke; Thomas Engber; Carol Huang; Jennifer Reilly; Stacy Tam; Donna Grant; Gregg Hetu; Russell C Petter
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
Journal of medicinal chemistry 2005;48(6):2009-18.
2005: Gang Yao; Serajul Haque; Li Sha; Gnanasambandam Kumaravel; Joy Wang; Thomas Engber; Eric T Whalley; Patrick R Conlon; Hexi Chang; William F Kiesman; Russell C Petter
Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.
Bioorganic & medicinal chemistry letters 2005;15(3):511-5.
2005: R Blake Pepinsky; Wen-Cherng Lee; Mark Cornebise; Alan Gill; K Wortham; Ling Ling Chen; Diane R Leone; Keith Giza; Brian M Dolinski; Stuart J Perper; Cheryl Nickerson-Nutter; Doreen J Lepage; Abhijit Chakraborty; Eric T Whalley; Russell C Petter; Steven P Adams; Roy R Lobb; Daniel M Scott
Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties.
The Journal of pharmacology and experimental therapeutics 2005;312(2):742-50.
2004: Hairuo Peng; Gnanasambandam Kumaravel; Gang Yao; Li Sha; Joy Wang; Herman van Vlijmen; Tonika Bohnert; Carol Huang; Chi B Vu; Carol L Ensinger; Hexi Chang; Thomas Engber; Eric T Whalley; Russell C Petter
Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists.
Journal of medicinal chemistry 2004;47(25):6218-29.
2004: Chi B Vu; Pamela Shields; Bo Peng; Gnanasambandam Kumaravel; Xiaowei Jin; Deepali Phadke; Joy Wang; Thomas Engber; Eman Ayyub; Russell C Petter
Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists.
Bioorganic & medicinal chemistry letters 2004;14(19):4835-8.
2004: Chi B Vu; Deborah Pan; Bo Peng; Li Sha; Gnanasambandam Kumaravel; Xiaowei Jin; Deepali Phadke; Thomas Engber; Carol Huang; Jennifer Reilly; Stacy Tam; Russell C Petter
Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles.
Bioorganic & medicinal chemistry letters 2004;14(19):4831-4.
2004: Chi B Vu; Bo Peng; Gnanasambandam Kumaravel; Glenn Smits; Xiaowei Jin; Deepali Phadke; Thomas Engber; Carol Huang; Jennifer Reilly; Stacy Tam; Donna Grant; Gregg Hetu; Liqing Chen; Jianbo Zhang; Russell C Petter
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
Journal of medicinal chemistry 2004;47(17):4291-9.
2004: Juswinder Singh; Steve Adams; Mary Beth Carter; Hernan Cuervo; Wen-Cherng Lee; Roy R Lobb; R Blake Pepinsky; Russell C Petter; Daniel Scott
Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma.
Current topics in medicinal chemistry 2004;4(14):1497-507.
2003: Diane R Leone; Keith Giza; Alan Gill; Brian M Dolinski; W Yang; Stuart J Perper; Daniel M Scott; Wen-Cherng Lee; Mark Cornebise; K Wortham; Cheryl Nickerson-Nutter; Ling Ling Chen; Doreen J Lepage; J C Spell; Eric T Whalley; Russell C Petter; Steven P Adams; Roy R Lobb; R Blake Pepinsky
An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis.
The Journal of pharmacology and experimental therapeutics 2003;305(3):1150-62.
2001: Ling Ling Chen; Adrian Whitty; D Scott; Wen-Cherng Lee; Mark Cornebise; Steven P Adams; Russell C Petter; Roy R Lobb; R Blake Pepinsky
Evidence that ligand and metal ion binding to integrin alpha 4beta 1 are regulated through a coupled equilibrium.
The Journal of biological chemistry 2001;276(39):36520-9.
1999: C Fotsch; Gnanasambandam Kumaravel; S K Sharma; A D Wu; JS Gounarides; NR Nirmala; Russell C Petter
On-resin macrocyclization of peptides via intramolecular SnAr reactions.
Bioorganic & medicinal chemistry letters 1999;9(15):2125-30.